EXPD vs MRSN · P/E 26, rev $6.29B vs rev $40.5M
Expeditors International of Washington, Inc. (EXPD) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the EXPD and MRSN stock pages for the full models.
Not investment advice.